The Hôpital Cochin is a hospital of public assistance in the rue du Faubourg-Saint-Jacques Paris 14e. It houses the central burn treatment centre of the city. The Hôpital Cochin is a section of the Faculté de Médecine Paris-Descartes.

During the past decade, Groupe Hospitalier Cochin conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe Hospitalier Cochin" #1 collaborator was "OptumInsight" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Cochin" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Delirium" (1 trials). Many other conditions were trialed in "Groupe Hospitalier Cochin" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier Cochin" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (1 trials), "PF-02341066" (1 trials), "Pemetrexed" (1 trials), "Sevoflurane" (1 trials) and "Xenon" (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier Cochin" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Groupe Hospitalier Cochin". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Groupe Hospitalier Cochin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier Cochin, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".